Expanded genetic testing and early transplant referrals anchor new myelofibrosis care recommendations
The American Society of Hematology (ASH) has released guidelines on the management of myelofibrosis, a rare and life-threatening blood cancer. The new guidelines recommend expanded molecular testing, early transplant referral, appropriate use of JAK inhibitors and aspirin therapy in select patients.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
